ABOUT US
TECHNOLOGY
BUSINESS
R&D
IR
PR
RECRUIT
ENG
KOR
ABOUT US
Greeting from the CEO
Vision & Mission
History
Partners
TECHNOLOGY
Core Technology
Multi-Omics
Microbiome
Metabolome
BUSINESS
Personalized Analysis Service
Health Functional Food
CDO(GMP)
R&D
Research Institute
Patents and Papers
Pharmabiotic(LBP)
Pipeline
IR
Announcements
Inquiries and Suggestions
PR
Notice
Media
RECRUIT
Talents
Welfare
Employment Notice
Employment FAQ
PMAS
MBR
Multi-Omics Research
NGS
Analysis of Metabolome
Management of Microbial Resource
Research on Development of New Drugs
A microbiome healthcare company
serving the value of healthy life
ABOUT US
Greeting from the CEO
Vision & Mission
History
Partners
TECHNOLOGY
Core Technology
PMAS
MBR
Multi-Omics
Multi-Omics Research
Microbiome
NGS
Metabolome
Analysis of Metabolome
BUSINESS
Personalized Analysis Service
Health Functional Food
CDMO(GMP)
R&D
Research Institute
Patents and Papers
Pharmabiotic(LBP)
Management of Microbial Resource
Research on Development of New Drugs
Pipeline
IR
Announcements
Inquiries and Suggestions
PR
Notice
Media
RECRUIT
Talents
Welfare
Employment Notice
Employment FAQ
A microbiome healthcare company
serving the value of healthy life
ABOUT US
Greeting from the CEO
Vision & Mission
History
Partners
TECHNOLOGY
Core Technology
PMAS
MBR
Multi-Omics
Multi-Omics Research
Microbiome
NGS
Metabolome
Analysis of Metabolome
BUSINESS
Personalized Analysis Service
Health Functional Food
CDMO(GMP)
R&D
Research Institute
Patents and Papers
Pharmabiotic(LBP)
Management of Microbial Resource
Research on Development of New Drugs
Pipeline
IR
Announcements
Inquiries and Suggestions
PR
Notice
Media
RECRUIT
Talents
Welfare
Employment Notice
Employment FAQ
ABOUT US
TECHNOLOGY
BUSINESS
R&D
IR
PR
RECRUIT
Media
'Live Biotherapeutic Product (LBP) 개발 및 기술 현황' 특강 _ (주)HEM Pharma 지요셉 대표
2022.09.21
한동대 'ESG 스타트업 허브 비전 선포식' 개최
2022.09.06
[암웨이의 집요한 인터뷰] 신개념 건강 플랫폼 "마이크로바이옴 솔루션"
2022.08.12
에이치이엠파마, 중기부 '예비유니콘' 선정 수여식
2022.08.10
에이치이엠파마, 중기부 예비유니콘 선정…최대 200억원 특별 보증 지원
2022.07.05
“암웨이와 ‘마이랩’ 통해 수많은 '장' 관련 데이터 분석으로 최적화된 개인 맞춤형 건강 솔루션을 제공할 수 있게 돼 너무 기쁘고 설레”
2022.05.24
에이치이엠파마, 109억원 규모 제3자배정 유상증자 납입 완료
2022.05.20
한국암웨이, 맞춤형 마이크로바이옴 솔루션 시장 진출
2022.05.20
에이치이엠파마, 한국암웨이와 맞춤형 마이크로바이옴 솔루션 출시
2022.05.20
에이치이엠파마, 머신러닝 통한 아토피·장염·변비 판별법 국내 특허 등록
2022.04.21
에이치이엠파마, 고부가가치 마이크로바이옴 기술로 신시장 개척
2022.03.20
에이치이엠파마, ‘맞춤형 장내 환경 개선 물질 스크리닝 기술’ 美 특허 취득
2022.03.15
1
2
3
4
5